doi: 10.1194/jlr.M010876 279 BirnbaumGCreeBAltafullahIZinserMRederAT
Common Side Effects Injection site reactions Headache Flushing Mild fluid retention Metabolic and Hormonal Considerations Potential alterations in glucose metabolism Elevated IGF-1 levels Theoretical risk of promoting tumor growth in predisposed individuals Key Limitation Most safety data comes from: Pediatric GH deficiency populations Adults with endocrine disorders There is limited long-term data in healthy, high-performing athletes
Daily use is not recommended
Macrophage Activation and Inflammatory Modulation: GHK-Cu demonstrates a nuanced relationship with inflammatory signaling
A protein BLAST search of this sequence performed against the human data base only matched some similar results, but far away from 100 % identity
Alongside it: MOTS-c (mitochondrial/metabolic), GHK-Cu (skin and repair), CJC-1295/Ipamorelin (the growth-hormone stack), Tesamorelin, Glutathione, NAD+, and even Retatrutide, the next-generation weight-loss peptide no other program reviewed here carries
